Nanatinostat TFA
Nanatinostat (CHR-3996) is an oral, second-generation HDAC inhibitor with antineoplastic potential. It promotes histone hyperacetylation and gene expression changes leading to cell cycle arrest and apoptosis, showing enhanced effects on HSP70 and Bcl-2 compared to earlier inhibitors. It has been investigated in preclinical models for hematological and solid tumors.
Product Specifications
CAS Number
1256448-48-2
Field of Research
Cell Biology, Epigenetics & Chromatin, Immunology & Inflammation, Molecular Biology
Smiles
OC (=O) C (F) (F) F.[H][C@@]12CN (C[C@]1 ([H]) [C@H]2NCc1ccc2cc (F) ccc2n1) c1ncc (cn1) C (=O) NO
Molecular Formula
C22H20F4N6O4
Molecular Weight
508.43
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![NDUFA1 (NADH Dehydrogenase [Ubiquinone] 1 alpha Subcomplex Subunit 1, Complex I-MWFE, CI-MWFE, NADH-ubiquinone Oxidoreductase MWFE Subunit) (HRP)](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
130205-HRP 100 µL
NDUFA1 (NADH Dehydrogenase [Ubiquinone] 1 alpha Subcomplex Subunit 1, Complex I-MWFE, CI-MWFE, NADH-ubiquinone Oxidoreductase MWFE Subunit) (HRP)
Sign In for Pricing
View Details 
7-07214 500 µg
Recombinant Hepatitis C Virus Nucleocapsid (core) 24
Sign In for Pricing
View Details